Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Holick

Showing results (171-180 of 246) with videos related to

Pageof 25
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 1998
Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3G G Schwartz, L W Whitlatch, T C Chen, et al.
The Journal of Pediatrics|June 1, 1994
A possible genetic defect in 25-hydroxylation as a cause of ricketsS J Casella, B J Reiner, T C Chen, et al.
The Journal of Biological Chemistry|January 25, 1976
Metabolism and biologicaM F Holick, L A Baxter, P K Schraufrogel, et al.
Endocrinology|June 1, 1981
1,25-dihydroxycholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormoneM E Holtrop, K A Cox, M B Clark, et al.
Biochemistry|August 19, 1980
Synthesis of [3 beta-3H]-3-epivitamin D3 and its metabolism in the ratS A Holick, M F Holick, J E Frommer, et al.
Journal of Cutaneous Pathology|October 23, 1997
Expression of integrin subunits and CD44 isoforms in psoriatic skin and effects of topical calcitriol applicationJ Reichrath, R Horf, T C Chen, et al.
The Journal of Biological Chemistry|February 25, 1976
Metabolism of 1alpha-hydroxyvitamin D3 in the chickS A Holick, M F Holick, T E Tavela, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancerT C Chen, G G Schwartz, K L Burnstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 1999
Molecular cloning, characterization, and promoter analysis of the human 25-hydroxyvitamin D3-1alpha-hydroxylase geneX F Kong, X H Zhu, Y L Pei, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1983
Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activationA K Bhalla, E P Amento, T L Clemens, et al.
Pageof 25

Showing results (171-180 of 246) with videos related to

Sort By:
Pageof 25
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 1998
Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3G G Schwartz, L W Whitlatch, T C Chen, et al.
The Journal of Pediatrics|June 1, 1994
A possible genetic defect in 25-hydroxylation as a cause of ricketsS J Casella, B J Reiner, T C Chen, et al.
The Journal of Biological Chemistry|January 25, 1976
Metabolism and biologicaM F Holick, L A Baxter, P K Schraufrogel, et al.
Endocrinology|June 1, 1981
1,25-dihydroxycholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormoneM E Holtrop, K A Cox, M B Clark, et al.
Biochemistry|August 19, 1980
Synthesis of [3 beta-3H]-3-epivitamin D3 and its metabolism in the ratS A Holick, M F Holick, J E Frommer, et al.
Journal of Cutaneous Pathology|October 23, 1997
Expression of integrin subunits and CD44 isoforms in psoriatic skin and effects of topical calcitriol applicationJ Reichrath, R Horf, T C Chen, et al.
The Journal of Biological Chemistry|February 25, 1976
Metabolism of 1alpha-hydroxyvitamin D3 in the chickS A Holick, M F Holick, T E Tavela, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancerT C Chen, G G Schwartz, K L Burnstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 1999
Molecular cloning, characterization, and promoter analysis of the human 25-hydroxyvitamin D3-1alpha-hydroxylase geneX F Kong, X H Zhu, Y L Pei, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1983
Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activationA K Bhalla, E P Amento, T L Clemens, et al.
Pageof 25